Loading...

Genetic deletion or pharmacologic antagonism of LPA(1) ameliorates dermal fibrosis in a scleroderma mouse model

OBJECTIVE: Scleroderma, or systemic sclerosis (SSc), is characterized by progressive multi-organ fibrosis. We recently implicated lysophosphatidic acid (LPA) in the pathogenesis of pulmonary fibrosis. Here we investigated the roles of LPA and two of its receptors, LPA(1) and LPA(2), in dermal fibros...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Castelino, Flavia V., Seiders, Jon, Bain, Gretchen, Brooks, Sarah F., King, Chris, Swaney, James S., Lorrain, Daniel S., Chun, Jerold, Luster, Andrew D., Tager, Andrew M.
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086986/
https://ncbi.nlm.nih.gov/pubmed/21305523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.30262
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!